USPages > Business Directory > BioTech Healthcare Medical Equipment > Boston Scientific Corp.

Boston Scientific Corp.

Industry: BioTech Healthcare Medical Equipment

Fortune Rank: 279

Boston Scientific Corporation engages in the development, manufacture, and marketing of medical devices that are used in interventional medical specialties. The company's products are offered by two groups, Cardiovascular and Endosurgery. The Cardiovascular organization provides products and technologies for use in interventional cardiology, peripheral interventions, vascular surgery, electrophysiology, and neurovascular procedures. The Endosurgery organization provides products and technologies for use in oncology, endoscopy, urology, and gynecology procedures. In addition, the company operates in the neuromodulation market. It provides products for the treatment of auditory disorders and chronic pain. The company’s less-invasive medical products are used for enlarging narrowed blood vessels to prevent heart attack and stroke; clearing passages blocked by plaque to restore blood flow; opening obstructions and bringing relief to patients suffering from various forms of cancer; performing biopsies and intravascular ultrasounds; mapping electrical problems in the heart; placing filters to prevent blood clots from reaching the lungs, heart, or brain; treating urological, renal, pulmonary, neurovascular, and gastrointestinal diseases; and modulating nerve activity to treat deafness and chronic pain. Boston Scientific markets its products through direct sales force, and a network of distributors and dealers. The company was founded by John E. Abele and Peter M. Nicholas in 1979. Boston Scientific is headquartered in Natick, Massachusetts.

Boston Scientific Corp.

Boston Scientific Corp. achieved revenue of $8,188.00 million in 2010 but posted a loss of $-1,025.00 million.

Boston Scientific Corp.' rank improves

The company ranking improved in 2010, moving up the Fortune 500 list to 279th compared to 320th in 2009. This was based on its 2009 revenue of $8,050 million (a change of 0 million compared to 2010) and profits of $-2,036 million (a change of $1 million compared to 2009).

Another point of view

To many investors, profits are more important than revenue a company earns, If the Fortune 500 was ranked by profits instead of revenue then Boston Scientific Corp. would be ranked 461st rather than 279th due to the fact it made a loss of $-1,025 million in 2010.

* US$ Million

• Address
  • Boston Scientific Corp.
    One Boston Scientific Place
    Natick
    MA
    01760
• Contact Details
  • Phone: 508-650-8000
  • Fax: 508-650-8923
  • Website: www.bsci.com
  • Stock Symbol: BSX

• Next Page: the 280th ranked company Ashland
• Previous Page: the 278th ranked company Republic Services